India’s first mRNA vax tech developed, to face corona test | India News

HYDERABAD: The Center for Cellular and Molecular Biology (CCMB) has developed India’s first indigenous mRNA vaccine technology for Covid-19. The vaccine technology, which is 90% effective against Covid-19 in the mouse model, can also be used to fight other infectious diseases like malaria, dengue and tuberculosis once the pandemic ends.
The new mRNA vaccine candidate is at a pre-clinical study stage where the efficacy of the technology will be tested against the live novel coronavirus infection.
Although there are mRNA (messenger RNA) vaccines developed by Pfizer and Moderna to prevent Covid-19, the CCMB’s mRNA vaccine technology is fully indigenous and was developed without any external scientific assistance. Also, it is different from the technology used in the mRNA vaccine by a Pune-based pharmaceutical firm currently under clinical trials in the country.
“The team at the Atal Incubation Center is involved in the CCMB-led development of a vaccine candidate within a year of project inception,” said Dr Vinay Nandicoori, Director of the CCMB.
As CCMB’s mRNA vaccine technology will redundant once the pandemic ends, Dr Vinay said the vaccine platform could also be used to prevent many infections in the country.

General Chat Chat Lounge

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker